Literature DB >> 33393792

Characteristics of U.S. Army Beneficiary Cases of COVID-19 in Europe, 12 March 2020-17 April 2020.

Tammy Servies.   

Abstract

In 2020, the SARS-CoV-2 virus caused an unprecedented pandemic of coronavirus disease 2019 (COVID-19). Army Public Health Command Europe monitored all cases of COVID-19 for Military Health System (MHS) beneficiaries seen in Army Military Treatment Facilities. Cases entered into the Army Disease Reporting System internet (ARDSi) were evaluated for symptomatology as this was a younger and healthier cohort than typically reported on at the time. During the surveillance period, 7.1% of COVID-19 cases among MHS beneficiaries were hospitalized; these cases presented with symptoms such as congestion, sore throat, and disturbances in taste and smell. Interventions to stop the outbreak included aggressive case finding with robust testing, control of cases and contacts, and the extreme social distancing measures seen in other countries. The outbreak was successfully brought under control in one month. Cases remained sporadic and were due largely to importation from the U.S. until the end of August 2020.

Entities:  

Year:  2020        PMID: 33393792

Source DB:  PubMed          Journal:  MSMR        ISSN: 2152-8217


  3 in total

1.  SARS-CoV-2 Transmission in the Military during the Early Phase of the Pandemic-A Systematic Analysis.

Authors:  Sylvia Xiao Wei Gwee; Pearleen Ee Yong Chua; Junxiong Pang
Journal:  Int J Environ Res Public Health       Date:  2022-06-16       Impact factor: 4.614

2.  Integration of Multiple Surveillance Systems to Track COVID-19 in the U.S. Army Population.

Authors:  Julianna Kebisek; Alexis Maule; Jacob Smith; Matthew Allman; Anthony Marquez; Ashleigh McCabe; Amelie Mafotsing Fopoussi; Kelly Gibson; Ryan Steelman; Michael Superior; John Ambrose
Journal:  Mil Med       Date:  2021-12-23       Impact factor: 1.563

3.  Trends in psychotropic drug consumption among French military personnel during the COVID-19 epidemic.

Authors:  Marc-Antoine Sanchez; Basile Fuchs; Pascale Tubert-Bitter; Anne-Sophie Mariet; Fabrice Jollant; Aurélie Mayet; Catherine Quantin
Journal:  BMC Med       Date:  2022-09-14       Impact factor: 11.150

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.